# Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children

> **NCT04377568** · PHASE2 · WITHDRAWN · sponsor: **The Hospital for Sick Children**

## Conditions studied

- Hospitalized Children
- Covid-19 Infection

## Interventions

- **BIOLOGICAL:** Convalescent plasma (CP)

## Key facts

- **NCT ID:** NCT04377568
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10-07
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no enrollment
- **Last updated:** 2021-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04377568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04377568, "Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04377568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*